INTRODUCTION
Neuromodulators, such as acetylcholine, serotonin, and adrenaline, have profound effects on neural circuits and behavior. On a cellular level, these neuromodulators activate G-protein-coupled receptors (GPCRs), which transduce these extracellular signals into changes in the biochemical and electrical state of cells (Lefkowitz, 2007) . Thousands of GPCRs encoded in mammalian genomes converge onto $20-Ga proteins that fall into four major classes. The class identity of the specific Ga protein coupled to each receptor determines which of several distinct signaling pathways are activated upon ligand binding and therefore is used to predict the function of the GPCR (Gilman, 1995; Lefkowitz, 2007) .
One of the most important signaling effectors of neuromodulator GPCRs is protein kinase A (PKA) (Dunn and Feller, 2008; Greengard, 2001; Williams et al., 2001 ). Classically, Gas-and Gai-coupled GPCRs up-and downregulate adenylyl cyclase activity, respectively, thereby controlling rates of production of cyclic AMP (cAMP), which activates PKA (Gilman, 1995) . This push-pull control of PKA activity bidirectionally regulates numerous physiological processes in the nervous system, including transcription, synaptic transmission, synaptic plasticity, calcium influx, and learning (Drain et al., 1991; Higley and Sabatini, 2010; Kandel and Abel, 1995; Seol et al., 2007; Shen et al., 2008; Skeberdis et al., 2006; Skoulakis et al., 1993; Williams et al., 2001; Zhong et al., 2009) .
Despite the importance of PKA for cellular physiology and animal behavior, our understanding of what neuromodulator inputs converge on PKA is incomplete. Notably, although Gas/Gaicoupled receptors clearly regulate PKA, whether Gaq-coupled receptors signal to PKA remains unclear. Classically, Gaqcoupled receptors signal to phospholipase C (PLC), and not PKA (Gilman, 1995; Hokin and Hokin, 1953) . Based on the specificity of Gaq coupling and the selective modulation of downstream signaling pathways, Gaq-coupled designer receptors have been broadly used to increase neuronal excitability, since PLC-mediated depletion of phosphatidylinositol 4,5-bisphosphate (PIP2) leads to closure of K + channels (Airan et al., 2009; Armbruster et al., 2007; Guettier et al., 2009; Spangler and Bruchas, 2017; Sternson and Roth, 2014) . Consequently, the effects of using Gaq-coupled designer receptors gated by light or exogenous small molecules are typically interpreted as resulting from manipulations of these classic Gaq effectors and not PKA. The widely held assumption of the selectivity of Gaq signaling seems at odds with the reported crosstalk from Gaq-coupled receptors to the adenylyl cyclase/cAMP/PKA module (Bandrowski et al., 2001; Baumgold and Fishman, 1988; Burford et al., 1995; Olianas and Onali, 1992; Stein et al., 1988; Wang et al., 2008) . Crosstalk can occur via direct coupling of Gaq-coupled receptors to Gas or Gai proteins (Burford and Nahorski, 1996; Masuho et al., 2015; Olianas and Onali, 1992; Stein et al., 1988) , or in principle via the intracellular effectors of the Gaq pathways (Cooper et al., 1995; Geoffroy et al., 1999; Hunter et al., 2009; Lee et al., 1994; Lustig et al., 1993; Shen et al., 2012; Yoshimasa et al., 1987) . However, for several reasons, the conclusions of these studies are insufficient to predict the effect of a specific, endogenously expressed Gaq-GPCR on PKA. First, different studies have reported that Gaq-coupled receptors increase, decrease, or do not change cAMP level/PKA activity, making it impossible to form a conclusion about the signaling downstream of a given GPCR. Second, although some intracellular effectors could potentially link a Gaq-GPCR to PKA based on studies in different cells and systems, the Gaq-GPCR may not actually regulate PKA in a given system because the receptor, the intracellular effector, and PKA may be anchored in different subcellular compartments or microdomains (Gray et al., 1998; Lur and Higley, 2015; Tsvetanova and von Zastrow, 2014; Zhang et al., 2013) . Third, many of these studies examined overexpressed receptors in heterologous systems, which often behave in qualitatively different ways to endogenous systems, because the nature of GPCR signaling is highly dependent on the expression level of GPCRs and their signaling effectors. Thus, it remains unclear whether endogenous Gaq-coupled receptors signal to PKA in the native brain, nor is it known in what context and cell types Gaq signaling regulates PKA activity.
Here, we examine the potential signaling to PKA by endogenous Gaq-coupled muscarinic acetylcholine receptors (mAChRs). PKA and mAChRs have each been identified as powerful regulators of synaptic plasticity, and their activity within the hippocampus promotes learning and memory (Brandon et al., 1997; Hasselmo, 2006; Higley and Picciotto, 2014; Seol et al., 2007; Skeberdis et al., 2006; Wess, 2004; Zhong et al., 2009) . Two classes of mAChRs are expressed in the hippocampus: the Gai-coupled mAChRs are expected to inhibit PKA, whereas the Gaq-coupled mAChRs are not classically predicted to signal to PKA (Caulfield, 1993; Hulme et al., 1990; Levey et al., 1995; Tice et al., 1996; Vilaró et al., 1990) . Understanding whether endogenous Gaq-coupled mAChRs signal to PKA will provide insight into the normal physiology of this highly conserved receptor family, the mechanisms of action of cholinergic drugs that are widely used to treat neuropsychiatric disorders (Higley and Picciotto, 2014; Thathiah and De Strooper, 2009) , and help with the prediction of cellular signaling and functions of the large family of Gaq-coupled receptors.
We use two-photon fluorescence lifetime imaging microscopy (2pFLIM) (Yasuda, 2006) and optical reporters of PKA activity that enable real-time analysis of endogenous GPCR signaling in acute hippocampal slices (Chen et al., 2014) . We found that, in hippocampal neurons, mAChR activation enhances phosphorylation by PKA. In addition, Gaq signaling is both sufficient and necessary for this unusual neuronal regulation of a classic Gas effector. Mechanistically, we revealed that mAChRs increase phosphorylation by PKA through parallel signaling via either Ca 2+ transients or PKC activation, mechanisms likely shared by the large family of Gaq-coupled neuromodulator receptors. Indeed, Gaq-dependent elevation of net PKA activity is induced by both multiple endogenous receptors and widely used Gaq-coupled designer receptors. Given the critical role of PKA in cellular physiology, circuit processing, and animal behavior, our findings enhance our ability to understand and predict cellular signaling and physiological function of the large family of Gaq-coupled receptors.
RESULTS mAChR Activation Increases Phosphorylation by PKA
In order to monitor PKA activity, we used our recently developed PKA activity sensor that allows quantitative real-time analysis of endogenous GPCR signaling with subcellular resolution in complex brain tissue (Chen et al., 2014) . PKA activity was reported by FLIM-AKAR, a PKA substrate and a Fö rster resonance energy transfer (FRET)-based optical reporter that we engineered for optimal 2pFLIM ( Figure 1A ). Upon phosphorylation by PKA, the PKA substrate consensus region of FLIM-AKAR binds to the phosphopeptide binding domain, increasing FRET between the donor and acceptor fluorophores and decreasing donor fluorescence lifetime. Thus, FLIM analysis of FLIM-AKAR provides a quantitative measurement of its phosphorylation status, which reflects the net activity of PKA and its phosphatases (we subsequently refer to this, for simplicity, as net PKA activity). In contrast to many other methods, this approach allows the real-time monitoring of PKA phosphorylation downstream of endogenous GPCRs with native signaling cascades. We targeted FLIM-AKAR to the hippocampus via in utero electroporation and observed robust expression in hippocampal pyramidal neurons ( Figure 1B) . To assess the effect of acetylcholine (ACh) on net PKA activity, we measured the fluorescence lifetime of FLIM-AKAR in CA1 pyramidal neurons in acute hippocampal slices using 2pFLIM. Tetrodotoxin (1 mM) was used in all experiments to block action (C) Heatmap of FLIM-AKAR lifetime in a hippocampal CA1 neuron (top, soma; bottom, primary apical dendrite), in response to acetylcholine (ACh, 100 mM) and subsequent forskolin (FSK, 50 mM) application. On the right are fluorescence intensity images to illustrate morphology. (D) The time course of net PKA activity in three subcellular compartments of the neuron in (C) during application of ACh and FSK. (E) Summaries of lifetime changes in the somatic cytoplasm during baseline, and in response to ACh and FSK (*p < 0.05 versus baseline; **p < 0.05 versus ACh). (F) Image with maximal projection of a z stack in the hippocampal CA1 region that shows the design of the ACh puffing experiment: ACh was puffed via a patching pipette (shown in red) onto an apical dendrite of a CA1 pyramidal neuron expressing FLIM-AKAR in acute hippocampal slices, and both apical and basal dendrites (imaged regions shown in the rectangles) were monitored for FLIM-AKAR lifetime change. (G) The time course of net PKA activity in apical and basal dendrites of the neuron imaged in (F) in response to 3 and 10 s ACh (200 mM) puffs. (H) X-Y summary plots of lifetime changes in the apical versus basal dendrites in response to 3 or 10 s ACh puffs. (I) As in (D) for a representative neuron during application of muscarine (mus, 10 mM) and FSK. (J) As in (E) in response to mus and subsequent FSK addition (*p < 0.05 versus baseline; **p < 0.05 versus mus). The composite data include stand-alone data as well as control datasets presented in other figures of this paper. Each square represents a data point and black lines show median values with interquartile intervals. (B) and (F) were stitched from multiple images. See also Figure S1 and Table S1. potentials. Surprisingly, ACh (100 mM) rapidly increased phosphorylation by PKA (as shown by a decrease in lifetime) in the somatic cytoplasm and dendrites (Figures 1C-1E and S1A-S1C;  Table S1 ; cytoplasm, n = 18, p < 0.0001 for baseline versus ACh; dendrites, n = 7, p = 0.016). The nucleus also showed a clear, but slower, response (n = 18, p = 0.0001). Subsequent addition of forskolin (FSK, 50 mM) to directly activate ACs and increase PKA activity further decreased fluorescence lifetime (cytoplasm, n = 18, p < 0.0001 for ACh versus FSK; nuclei, n = 18, p < 0.0001; dendrites, n = 7, p = 0.016) and was used as a positive control for cell health and responsiveness to adenylyl cyclase (AC) activation in all experiments.
In order to mimic localized and transient ACh release in vivo, we puffed ACh (200 mM) onto apical dendrites with comparable temporal durations to ACh release measured in behaving mice ( Figure 1F ) (Parikh et al., 2007) . Net PKA activity increased transiently in stimulated dendrites, with larger responses to 10 s than 3 s exposures (Figures 1G and 1H ; n = 10, p = 0.014 for baseline versus 10 s). In contrast, no response was observed in the unstimulated basal dendrite of the same neuron (n = 10, p = 0.32 for baseline versus 10 s), which can respond when directly exposed to ACh ( Figure S1D ). Thus, ACh increases phosphorylation by PKA with spatial and temporal precision.
We hypothesized that activation of the G-protein-coupled ACh receptors, mAChRs, is sufficient to increase net PKA activity. Indeed, muscarine (mus, 10 mM) application reduced lifetime in all three subcellular compartments ( Figures 1I-1J , S1E, and S1F; cytoplasm, n = 55; nuclei, n = 55; dendrites, n = 16; p < 0.0001 for all for baseline versus mus). Strikingly, the amplitude of the lifetime change in response to mus is similar to that in response to the Gas-coupled b-adrenergic receptor agonist isoproterenol (iso) (Figures S2A and S2B) . Interestingly, most cells showed a sustained lifetime decrease to mus and a transient lifetime decrease to iso. Finally, mus-induced FLIM-AKAR phosphorylation was abolished in the presence of the mAChR antagonist scopolamine (10 mM) (Figures S2E and S2F; n = 17; p = 0.58 for baseline versus mus [cytoplasm] , p = 0.43 [nucleus] ), confirming the specificity of mus to mAChRs. Thus, mAChR activation is sufficient to increase phosphorylation by PKA.
The specificity for PKA of the reporter's response was examined in two different ways. First, mAChR-induced FLIM-AKAR phosphorylation was significantly reduced by expression of a reporter with a point mutation (mut) that renders it not phosphorylatable by PKA (Figures 2A-2C and S3A) (cytoplasm and nuclei, n = 8 wild-type [WT] , n = 14 [mut], p < 0.0001 for WT versus mut in both compartments; dendrites, n = 4 [WT], n = 7 [mut], p = 0.024). This indicates that the phosphorylatable residue is required for mAChR-induced reporter response. Second, expression of the PKA inhibitor PKI (Dalton and Dewey, 2006; Walsh et al., 1971) , which is excluded from the nucleus (Wen et al., 1995) (Figures 2D-2F ), yet cell health was unaffected as indicated by the electrical properties of the neurons ( Figure S3B ). Thus, PKA activity is required for mAChR-induced reporter response.
To further test the conclusion that net PKA activity increases in response to mAChRs, we developed a second method to measure activation of PKA that is independent from and orthogonal to FLIM-AKAR. This FRET-based optical reporter, PSI (for PKAc-substrate interaction), directly measures the physical interaction of PKA catalytic subunit (PKAc) with a substrate (Figure 2G) . PSI consists of two molecules: (1) PKAc fused with monomeric enhanced GFP (mEGFP) (Zhong et al., 2009) , which is excluded from the nucleus, and (2) monomeric cherry protein (mCherry) fused with a consensus region of PKA substrates with a point mutation that renders the substrate not phosphorylatable. Upon elevation of cAMP, PKAc-mEGFP is liberated from the regulatory subunits of PKA and binds to the mCherry-tagged PKA substrate, leading to FRET. Thus, PSI reports activation of PKA by monitoring the interaction between PKAc and its substrates, whereas FLIM-AKAR reports phosphorylation by endogenous PKA, making them independent methods of monitoring PKA activation. In response to mus, the PSI reporter showed increased FRET (Figures 2H and 2I ; n = 11, p = 0.0098 for baseline versus mus), demonstrating that mus induces the interaction between PKAc and the substrate. Therefore, results from the two orthogonal optical sensors indicate that mus activates PKA.
Since the PKA response is qualitatively similar in all subcellular compartments, we focus our report on the somatic cytoplasm and include nuclear data in the supplemental figures.
Gaq-Coupled mAChR Activation Increases Net PKA Activity Gai-coupled GPCRs inhibit PKA activity, yet we observed increased net PKA activity in response to mus. Therefore, we hypothesized that Gaq-coupled mAChRs are sufficient to increase net PKA activity. We tested this hypothesis by activating endogenous Gaq-coupled M1 mAChRs (M1Rs) with the specific agonist 77-LH-28-1 (LH) (Langmead et al., 2008) . Application of LH (10 mM) induced a large decrease in reporter lifetime to a similar degree as mus ( Figures 3A, 3B , S4A, and S4B; n = 13, p = 0.0007 for baseline versus LH). Furthermore, LH-induced FLIM-AKAR phosphorylation was abolished in the presence of the mAChR antagonist scopolamine (10 mM) (Figures S2G and S2H; n = 9, p = 0.36 for baseline versus LH), confirming the selectivity of LH to mAChRs. These experiments reveal that activation of Gaq-coupled mAChRs is sufficient to enhance PKA phosphorylation in the hippocampus.
Such signaling from M1Rs to PKA may contribute to previously described but mechanistically poorly understood contributions of PKA to mAChR-dependent synaptic plasticity in pyramidal neurons (Dickinson et al., 2009; Jo et al., 2010; Seol et al., 2007) . Indeed, inclusion of PKI in the recording pipette prevented M1R-induced synaptic depression ( Figure S5 ; control, n = 11, p = 0.0020 for baseline versus LH; PKI, n = 12, p = 0.23 for baseline versus LH; p = 0.0070 for control versus PKI after LH treatment). Thus, PKA activity is required for M1R-induced synaptic depression, providing functional implications of our finding.
In principle, Gaq-coupled receptors may increase net PKA activity via Gaq signaling, or by promiscuous coupling to Gas. Therefore, we used YM-254890 (YM), a specific inhibitor of the Gaq family of heterotrimeric G proteins (Gaq/G 11 /G 14 ) (Nishimura et al., 2010), to test whether mus-induced increase in net PKA activity requires Gaq signaling. Using the genetically encoded Ca 2+ indicator GCaMP (Tian et al., 2009; Zariwala et al., 2012) , we found that application of YM (1 mM) inhibited mus- Table S1 . p = 0.0082 for control versus YM with mus). Furthermore, PKA activation in response to the activation of Gas-coupled receptors remains intact in the presence of YM (Figures S2A and S2B; n = 5 for control, n = 8 for YM, p = 0.62 for control versus YM with iso), confirming that YM did not inhibit Gas signaling. These positive and negative controls thus validate the utility of YM in determining the Gaq dependence of mus-triggered activation of PKA in our system. In HEK cells, PKA activation by overexpressed M1Rs was unaffected by YM application ( Figure S6 ; n = 9, p = 0.0039 for baseline versus mus with YM), consistent with previous reports of Gas coupling with overexpressed Gaq-GPCRs in heterologous systems (Burford and Nahorski, 1996) . In contrast, YM significantly reduced endogenous mAChR-induced FLIM-AKAR phosphorylation in hippocampal CA1 pyramidal neurons ( Figures 3C, 3D , S4C, and S4D; n = 16 for control, n = 25 for YM, p < 0.0001 for control versus YM with mus), indicating that signaling through the Gaq family is required for mus-induced increase in net PKA activity in the hippocampus. (Berridge, 1983; Berridge et al., 1983; Kirk et al., 1981) . IP 3 binding to its receptor leads to release of Ca 2+ from intracellular stores; DAG or Ca 2+ binds and activates PKC Streb et al., 1983; Takai et al., 1977) ( Figure 4A ). Thus, we investigated the involvement of the two branches of signaling pathways immediately downstream of PLC.
Since Ca 2+ -activated ACs are expressed in the hippocampus (Cooper et al., 1995) PKC Is Sufficient to Increase, but Not Necessary for, mAChR-induced Net PKA Activity To probe the potential involvement of the second arm of Gaq signaling-activation of PKC-in mAChR-induced net PKA activation, we first examined whether PKC could non-specifically phosphorylate the reporter FLIM-AKAR. Consistent with previous results (Allen and Zhang, 2006) , in HEK cells, application of phorbol 12,13-dibutyrate (PDBu, 1 mM), a DAG derivative that activates PKC, did not change FLIM-AKAR lifetime ( Figure 5A ; n = 12, p = 0.27 for baseline versus PDBu, p = 0.0005 for baseline versus FSK), indicating that PKC does not phosphorylate the reporter directly.
In the hippocampus, however, PDBu application robustly decreased reporter lifetime ( Figures 5B, S7C , and S7D; n = 31, p < 0.0001 for baseline versus PDBu). This demonstrates that PKC activation is sufficient to increase net PKA activity in the hippocampus, but not HEK cells, revealing cell-type-specific regulation of PKA by PKC.
Biochemical evidence has demonstrated that PKC can phosphorylate adenylyl cyclase 2 (AC2) (Lustig et al., 1993 ; Shen Table S1 . Yoshimasa et al., 1987) , which is expressed in the hippocampus (Allen Developing Mouse Brain Atlas, 2008) . To test whether AC2 can mediate PKC modulation of net PKA activity in our system, we transfected HEK cells with recombinant mouse Adcy2. FLIM-AKAR lifetime decreased in response to PDBu in Adcy2-transfected cells ( Figure 5C ; n = 4 for control cells, n = 11 for Adcy2-transfected cells, p = 0.0015 for control versus Adcy2 for PDBu condition), showing that expression of Adcy2 confers PKA modulation by PKC in HEK cells. Together, these experiments show that PKC is sufficient to increase net PKA activity in the hippocampus and suggest that Adcy2 expression may account for the cell-type-specific regulation of PKA by PKC.
Since PKC activation is sufficient to increase net PKA activity in the hippocampus, we hypothesized that PKC is required for mAChR-induced phosphorylation by PKA. To test this, we applied the PKC inhibitor GF109203X (2 mM) to acute hippocampal slices. The inhibitor blocked PDBu-induced FLIM-AKAR Figure S7 and Table S1 .
phosphorylation (Figures S2I and S2J ; n = 12, p > 0.05 for baseline versus PDBu). However, in the presence of the PKC inhibitor, mus induced a decrease in fluorescence lifetime that was larger than in control ( Figures 5D, S7E , and S7F; n = 8 for control, n = 18 for GF109203X, p = 0.0075 for control versus GF109203X with mus). Together, these experiments show that activation of PKC is sufficient to increase PKA phosphorylation but is not required for mAChR-induced net PKA activation. . Notably, under these treatment conditions, although mAChR-induced net PKA activation is largely abolished, activation of the Gas-coupled b-adrenergic receptor with its agonist iso still decreased FLIM-AKAR lifetime (Figures 6C and S7I ; n = 18, p < 0.0001 for baseline versus iso). These results, in addition to those with YM described above, demonstrate that net PKA activation does not simply occur due to non-specific coupling between mAChRs and Gas; instead, Gaq-and Gas-coupled receptors elevate net PKA activity through pharmacologically distinguishable mechanisms.
In summary, the results from mechanistic explorations reveal a pathway wherein Gaq-coupled mAChR activation increases net PKA activity via either PKC activation or Ca 2+ transient ( Figure 6D ).
Multiple Gaq-Coupled Receptors Increase Net PKA Activity Since Gaq induction of PKC activation and Ca 2+ transients is not specific to mAChRs, we predicted that the unexpected signaling to a pathway normally associated with Gas is a general feature of Gaq-coupled receptors. To test this prediction, we examined the effects of activating endogenous Gaq-coupled Group I metabotropic glutamate receptors (mGluRs) in hippocampal CA1 pyramidal neurons ( Figure 7A ). Activation with the Group I mGluR agonist DHPG (50 mM) significantly decreased FLIM-AKAR lifetime ( Figures 7B, S8A , and S8B; n = 8, adjusted p = 0.047 for baseline versus DHPG), indicating that net PKA activation occurs downstream of multiple endogenous Gaq-coupled receptors. In addition to endogenous receptors, we tested our prediction using hM3Dq, a widely used designer receptor exclusively activated by designer drugs (DREADD) that is Gaq coupled ( Figure 7A ) (Armbruster et al., 2007) . Application of the ligand clozapine-N-oxide (CNO, 10 mM) induced net PKA activation in hM3Dq-transfected CA1 pyramidal neurons in acute hippocampal slices and occluded subsequent cytoplasmic mus response ( Figures 7C, 7D , S8C, and S8D; n = 9, adjusted p = 0.012 for baseline versus CNO; p = 0.73 for CNO versus CNO+mus). Importantly, Gaq signaling is required for hM3Dq-induced increase in net PKA activity (Figures S8E and S8F ; n = 9 for control, Table S1 . n = 10 for YM, p = 0.0003 for control versus YM with CNO), showing that the response is not due to ectopic Gas coupling by the heterologous expression of hM3Dq. Finally, we also found that activation of hM3Dq increased PKA activity in a separate system (organotypic hippocampal slices) and with a separate reporter (the PSI reporter) (Figures S8G and S8H ; n = 8, p = 0.0078 for baseline versus CNO). Thus, elevation of net PKA activity occurs with multiple Gaq-coupled receptors, including both endogenous receptors and those that are ectopically expressed.
DISCUSSION
Here, we study endogenous GPCRs in native brain tissue using optical reporters of PKA activation. We reveal the regulation by Gaq-coupled neuromodulator receptors of net PKA activitythe signal transduction effector classically associated with the Gas and Gai pathways (Figure 8) . Mechanistically, the regulation is mediated via either PKC activation or Ca 2+ transients. Furthermore, the findings generalize across multiple Gaq-coupled GPCRs, as evidenced by the net PKA response to activation of M1Rs, Group I mGluRs, and Gaq-coupled designer receptors. Together, these results show that one major family of GPCRs signal to the effector of another. Our results provide an important addition to the classical model of GPCR signaling and highlight PKA as an integrator of three major types of neuromodulator inputs (Gas-, Gai-, and Gaq-coupled receptors) in the brain.
Modulation of Net PKA Activity by Gaq-Coupled Neuromodulator Receptors Although previous studies have implicated Gaq regulation of PKA, it was not possible to predict the directionality of the PKA response and thus the cellular function of a given Gaq-coupled receptor. Studies of GPCRs overexpressed in cell lines had demonstrated that Gaq-coupled receptors (e.g., M1Rs) can activate Gaq, Gas, or Gai signaling modules by coupling to each class of G protein (Burford and Nahorski, 1996; Felder et al., 1989; Peralta et al., 1988; Stein et al., 1988) . Intracellularly, Ca 2+ and PKC can have diverse effects on adenylyl cyclases, phophodiesterases, phosphatases, and kinases, thereby potentially increasing or decreasing net PKA activity (Armstrong, 1989; Cooper et al., 1995; Geoffroy et al., 1999; Hunter et al., 2009; Lee et al., 1994; Lustig et al., 1993; Shen et al., 2012; Yoshimasa et al., 1987) . This myriad of reports makes divergent and often conflicting predications about the potential of PKA modulation by Gaq-coupled receptors. Furthermore, many studies used overexpressed receptors or intracellular signaling components, likely introducing artifacts due to overexpression (Gibson et al., 2013) . Finally, cellular signaling is highly spatiotemporally regulated (Gray et al., 1998; Lur and Higley, 2015; Tsvetanova and von Zastrow, 2014; Zhang et al., 2013) , making it difficult to predict the effect of PKA regulation by an endogenous Gaq-coupled receptor in a specific brain region and cell type.
For these reasons, we monitored the time course of net PKA activity in individual cells in response to endogenous GPCR signaling in brain tissue, thereby revealing Gaq-GPCR modulation of net PKA activity in the brain regions and cells where they function. The importance of this approach is made clear here as the modulation of PKA by endogenous mAChRs in the hippocampus requires Gaq signaling ( Figures 3C, 3D, S4C , and S4D), whereas that by overexpressed M1Rs in HEK293T cells does not ( Figure S6) , with the latter likely reflecting ectopic Gas coupling of overexpressed M1Rs.
Since FLIM-AKAR reports phosphorylation of a PKA substrate, the increase in net PKA activity in response to Gaq activation could be due to an increase in PKA activity or a decrease in phosphatase activity. To distinguish these possibilities, we designed a second optical reporter (PSI) that reports the physical interaction between the catalytic subunit of PKAc and a PKA substrate ( Figure 2G ). Using PSI, we demonstrated enhanced PKAc/substrate interaction upon activation of mAChRs ( Figures  2H and 2I) . Thus, although we cannot rule out additional contributions of downregulation of phosphatase activity, the results from both optical reporters show that activation of mAChR increases PKA activity. Each square represents a data point and black lines show median values with interquartile intervals. See also Figure S7 and Table S1 .
The FRET-FLIM based reporters can report PKA activity with subcellular spatial resolution and sub-second temporal precision (Chen et al., 2014) and thus provides additional spatiotemporal information on the PKA response to activation of Gaq. First, brief ACh application at specific dendritic branches with durations observed in vivo led to dendrite-specific and temporally transient net PKA activation ( Figures 1F-1H and S1D) . Second, the reporter revealed heterogeneity of responses across cells, and demonstrated Gaq-mediated reporter phosphorylation in the cytoplasm, nucleus, and dendrites (Figures 1 and S1 ). Third, real-time monitoring of net PKA activity showed a temporal delay of nuclear response compared with cytoplasm and dendrites ( Figure 1I ), likely due to the diffusion of cAMP, PKA, or phosphorylated PKA substrates such as the reporter from somatic cytoplasm into the nucleus (Chen et al., 2014) . Finally, the reporter allowed us to observe acute responses to neuromodulator receptor stimulation, disambiguating between acute versus adaptive changes. These findings would be hard or impossible to capture with traditional biochemical methods that take a snapshot of the average response of a population of cells.
The Molecular Mechanisms of Gaq-GPCR Modulation of Net PKA Activity
We show that Gaq regulation of PKA can occur via either Ca 2+ or PKC-dependent pathways. Previous work with overexpressed M1 receptors in CHO cells showed that M1Rs could couple directly to Gas (Burford and Nahorski, 1996) . This is unlikely to be the case in the hippocampus based on our data from two experiments. First, data with the Gaq inhibitor YM showed that Gaq signaling is required for mAChR-induced increase in PKA phosphorylation ( Figures 3C, 3D, S4C, and S4D) . Second, mAChR-mediated net PKA activity in the soma was abolished with concurrent inhibition of Ca 2+ transients and PKC, whereas the Gas-coupled beta-adrenergic response was still present ( Figures 6C and S7I) . Thus, the Gas-and Gaq-coupled receptors employ pharmacologically distinguishable mechanisms to modulate net PKA activity in the hippocampus. Any studies using biosensors and pharmacology require selectivity of the sensors and pharmacological reagents. We addressed the biosensor selectivity using two orthogonal sensors (FLIM-AKAR and PSI) (Figures 1 and 2G-2I ), whose mechanisms of sensing are independent of each other. To dissect the intracellular mechanisms, we targeted multiple nodes of the Gaq-GPCR signaling pathway. We show that regulation of PKA by GaqmAChR requires (1) mAChR activity ( Figures S2E-S2H ), (2) Gaq signaling ( Figures 3C, 3D, S4C , and S4D), (3) either Ca 2+ transient or PKC activation (Figures 4, 5, 6 , and S7), and (4) PKA activity (Figures 2 and S3 ). Although we cannot rule out complex contributions from other potential pathways, the preponderance of evidence indicates that the most parsimonious mechanism for Gaq-GPCR regulation of PKA activity is via bona fide Gaq signaling, mediated by either Ca 2+ or PKC-dependent pathways.
The existence of multiple signaling pathways from GPCR activation to the same apparent outcome (i.e., enhanced phosphorylation by PKA) may provide several advantages. First, it may allow more precise spatiotemporal regulation of PKA activity. PKC-mediated mAChR regulation of PKA may, like Gas/Gaidependent regulation (Lur and Higley, 2015; Zhang et al., 2013) , be limited to signaling microdomains and thus highly compartmentalized. Ca 2+ -mediated regulation of PKA, on the other hand, may lead to spatially broader cellular changes, since Ca 2+ is released from intracellular stores into the cytoplasm, and not in a membrane-delineated fashion. Second, these pathways could cooperate to ensure the robustness of the response. Third, the existence of two pathways allows integration of a specific neuromodulator input with a wider range of other extracellular signals that impact the signaling components. Finally, these Figure S8 and Table S1 .
mechanisms predict the existence of positive and negative feedback loops. PKA activation can phosphorylate and modulate Ca 2+ permeability of voltage-gated Ca 2+ channels and NMDA receptors (Skeberdis et al., 2006; Vandael et al., 2013) , and the resultant Ca 2+ entry would in turn modulate both PKA and PKC activity (Cooper et al., 1995; Huang, 1989) . PKC activation can also phosphorylate both adenylyl cyclase and phosphodiesterases (Geoffroy et al., 1999; Hunter et al., 2009; Lee et al., 1994; Lustig et al., 1993; Shen et al., 2012; Yoshimasa et al., 1987) , which would increase and decrease PKA activity, respectively. Thus, these mechanisms could potentially generate complex transients of PKA activity in response to certain patterns of neuromodulator inputs. The molecular mechanisms elucidated here help predict where and when Gaq-PKA signaling can occur. Since molecular components such as PLCb and PKC are widely expressed, whether Gaq signals to PKA likely depends on the availability of specific ACs: AC2 for the PKC-mediated pathway and AC1/ AC8/soluble adenylyl cyclase for the Ca 2+ -mediated pathway (Cooper et al., 1995; Dunn et al., 2009) . Differential distribution of ACs may act as a cellular or subcellular code to engage neither, one, or both arms of the Gaq pathway. This may explain, for example, why activation of the designer receptor hM3Dq increases PKA activity in the hippocampus ( Figures 7C, 7D , and S8C-S8H), but not in COS7 or pancreatic b cells (Guettier et al., 2009) . Thus, the cell-type specificity conferred by molecular components may explain seemingly conflicting observations and mechanisms across different cell lines and cell types (Bandrowski et al., 2001; Baumgold and Fishman, 1988; Onali and Olianas, 1990; Wang et al., 2008) and could give rise to functional specificity to Gaq signaling in different cell types and subcellular compartments.
Implications of Gaq-GPCR Modulation of Net PKA Activity PKA phosphorylates many neurotransmitter receptors, ion channels, and transcription factors and is associated with synaptic plasticity (Esteban et al., 2003; Higley and Sabatini, 2010; Kandel and Abel, 1995; Lerner and Kreitzer, 2011; Seol et al., 2007; Shen et al., 2008; Skeberdis et al., 2006; Woolfrey and Dell'Acqua, 2015; Yasuda et al., 2003) . Therefore, Gaq-mediated activation of net PKA activity has functional implications for a large family of GPCRs. For example, we showed that PKA activity is required for synaptic depression induced by the Gaq-coupled M1Rs ( Figure S5 ). In addition, modulation of PKA by Gaq-coupled GPCRs likely explains previous biochemical findings such as the phosphorylation of GluA1 at the PKA phosphorylation site by M1R activation (Seol et al., 2007) and the regulation of Gas signaling by Gaq-coupled receptors (Brown and Rietow, 1981; Cartmell et al., 1998; Enyedi et al., 1982; Goureau et al., 1990) . Furthermore, Gaq-PKA coupling may contribute to multiple physiological and therapeutic processes, such as the mechanism of action for cholinergic drugs used to treat neuropsychiatric diseases (Higley and Picciotto, 2014; Thathiah and De Strooper, 2009) and amnesia induced by the mAChR antagonist scopolamine (Deutsch and Rocklin, 1967) . Finally, this signaling pathway is likely conserved across species, as suggested by the mus-induced and PKA-dependent enhancement of stridulation in grasshoppers (Wenzel et al., 2002) .
In addition to the explanatory value, the results of this study provide both practical and conceptual insights into the biology and experiments involving Gaq-coupled receptors. First, they inform the design and interpretation of experiments utilizing Gaq-coupled designer receptors, which will also engage PKA, a Gas signaling effector, in specific cell types. Second, screening assays designed to identify ligands for orphan GPCRs suffer from a lack of knowledge in their G protein coupling and downstream signaling. The observation and molecular mechanisms elucidated here will allow investigators to engineer cell lines with the molecular components of the Gaq/PKA signaling and use them to deorphanize three major families of GPCRs with a single PKA activity assay. Third, modulation of net PKA activity is likely to be a general feature of Gaq-coupled neuromodulator receptors based on the mechanisms we have elucidated, and so the findings help predict cellular signaling and function for the large family of Gaq-coupled GPCRs. Finally, they reveal PKA as an integrator of cellular signaling from activation of the Gas, Gai, and Gaq-coupled neuromodulator receptors, adding an important branch to models of GPCR signaling and opening new directions of study on the integration of different classes of neuromodulators by PKA.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
HEK293T Cells HEK293T cells (Invitrogen) were cultured in DMEM with 10% FBS, sodium pyruvate (1 mM), L-glutamine (2 mM), and penicillin (50 U/ml) /streptavidin (50 mg/ml) (all reagents from GIBCO) at 37 C in 5% CO 2 . The gender of the cells is female. The cell line has not been authenticated. They were used as a non-neuronal cell line to verify that FLIM-AKAR was not directly phosphorylated by PKC, and were not tested for mycoplasma. They were plated on coverslips in 24-well plates and transfected with the plasmid AAV-FLIM-AKAR, AAV-FLIM-AKAR and mouse adcy2, or AAV-FLIM-AKAR and pcDNA3.1-human M1R using Lipofectamine 2000 (Invitrogen). One or two days after transfection, the cells were imaged in solutions containing either HEPES-based buffer (containing in mM: 130 KCl, 1 EGTA, 1 MgCl 2 , 25 HEPES, 10 glucose, 20 sucrose, pH with KOH to 7.4) or ACSF (see below).
Animals
All procedures for rodent husbandry and surgery were performed following protocols approved by the Harvard Standing Committee on Animal Care and in accordance with National Institutes of Health guidelines. C57BL/6 wild-type mice (Charles River) between postnatal days 15 and 19 (P15-P19) were used for PKA imaging experiments and for Ca 2+ imaging experiments in Figures S2C and S2D, and mice at P21-P28 were used for Figure S5 . For Ca 2+ imaging experiments in Figure 4 , the Ai38 mouse with GCaMP3 f/f genotype (Tian et al., 2009; Zariwala et al., 2012) (MGI: 5014745; RRID: IMSR_JAX:014538) at age P27-P38 were used. Both male and female mice were used.
Since we observed a bigger mus-induced increase in net PKA activity with enriched environment, all experiments with FLIM imaging of the PKA reporter were performed following environment enrichment. This involves transfer of animals at P4-P7 to a larger cage that contained a shack, 3-4 pieces of nestlets, a tunnel, a hut, a running wheel, and a novel toy, as well as embedded yogurt drops in the bedding. To maximize novelty exposure of the animals, the hut, wheel, and novel toy were replaced with the same types of objects, but with different colors and shapes every other day. Fresh yogurt drops were also embedded in the bedding every other day.
Organotypic Hippocampal Cultures
For the experiments in Figures S8G and S8H , organotypic hippocampal slices were cultured from 7 days old Spraque Dawley rats (Stoppini et al., 1991) . Both male and female rats were used. The brain was dissected and immediately placed in cold dissection media. Transverse hippocampal slices were cut with 400 mm thickness and placed above a sterile culture insert (Millicell-CM, Millipore) in 6-well plates containing prewarmed culture media. DNA plasmids were biolistically transfected with a Helios Gene Gun (Biorad) 5-7 days after culturing, and the slice were imaged 3-4 days after transfection.
METHOD DETAILS
DNA Plasmids
The constructs AAV-FLIM-AKAR, AAV-FLEX-FLIM-AKAR, AAV-FLEX-FLIM-AKAR T391A and AAV-FLEX-PKIa-IRES-mRuby2 were described in Chen et al. (2014) (Addgene #s 63058, 60445, 60466 and 63059) . pCMV-SPORT6-adcy2 was an IMAGE clone from Invitrogen (IMAGE: 5367175; Lennon et al., 1996) . pcDNA3.1-human M1R was from cDNA Resource Center (http://www.cdna.org/ home.php?cat=0). PKAc-mEGFP (pCAGGSS-mouse PKA-Calpha-mEGFP) was a gift from Haining Zhong (Addgene # 45528) (Zhong et al., 2009 , 2011) . The AAV-Cre-mCherry construct was from Matthew During at Ohio State University. AAV-DFI-Gcamp3.8 was cloned by replacing ChR2-mCherry in AAV-EF1a-DFI-ChR2-mCherry (Cardin et al., 2009 ) with Gcamp3.8. For the construction of the mCherry-tagged PKA consensus substrate, the mEGFP and sReaCh regions of AAV-FLEX-FLIM-AKAR were each replaced by mCherry through gene synthesis and subcloning via ApaI and BglII sites. Subsequently, sitedirected mutagenesis was performed to mutate the threonine to alanine at the phosphorylation site of the consensus substrate (Genscript).
In Utero Electroporation
In utero electroporation was used to deliver plasmids as described previously (Chen et al., 2014) . During electroporation, the embryo head was held with a tweezertrode (5mm electrode diameter, Harvard Apparatus) and electric pulses were delivered five times (50 V, 50 ms pulse with 950ms interval) for hippocampus delivery of DNA (CUY21 electroporator, NEPA GENE, Japan).
Virus Production and Stereotaxic Injections
For GCaMP3 imaging, AAV1-Cre-mCherry and AAV8-DFI-Gcamp3.8 were packaged at University of North Carolina Gene Therapy Center Virus Core Facility. For Figures 4B-4D , P16-P21 pups with the genotype GCaMP3 f/f were anesthetized with isofluorane and placed on a small stereotaxic frame (David Kopf Instruments). To target the hippocampus, coordinates of posterior 2.8 mm and lateral 3.0 mm relative to Bregma, 2.2 mm from the pia were used. Unilateral injections of 1 mL of AAV1-Cre-mCherry (2 3 10 12 genome copy/ml) were made into the right hemispheres at a rate of 100 nl/min through a UMP3 micro syringe pump (World Precision Instruments). After injection, pups were returned to their home cage with their mother, weaned around P21-P23, and expression was allowed to occur for at least 11 days post infection. For Figures S2C and S2D , AAV1-Cre-mCherry (2 3 10 12 genome copy/ml) and AAV-DFI-Gcamp3.8 (1.39X10 12 virus molecules/ml) were injected into P0/P1 hippocampus according to previously published procedures , and mice were imaged at P15-P19.
Brain Slice Preparation
Mice were anesthetized with isoflurane before being sacrificed. Their brains were rapidly dissected out.
For all the experiments except for those in Figures S5, S8G , and S8H, acute horizontal sections were sliced from the hippocampus with a Leica VT1000S vibratome (Leica Instruments) in cold sucrose cutting solution (containing in mM: 87 NaCl, 25 NaHCO3, 1.25 NaH2PO4 2.5 KCl, 75 sucrose, 25 glucose, 7.5 MgCl2). Slices were 300 mm thick. After sectioning, slices were transferred to ACSF (containing in mM: 127 NaCl, 2.5 KCl, 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 2 CaCl 2 , 1 MgCl 2 , and 25 glucose; for nominal 0 Ca 2+ experiments, ACSF contained no CaCl 2 and 3 MgCl 2 ). The slices were incubated for recovery at 34 C for 5-10 minutes (imaging experiments) or 30 minutes (electrophysiology recordings), and then kept in ACSF at room temperature. Slices were then transferred to a microscope chamber and ACSF was perfused at a flow rate of 2-4 ml/min.
For the experiments in Figure S5 , acute visual cortical slices (300 mm) were prepared as described (Seol et al., 2007) . Briefly, slices were sectioned in ice-cold cutting buffer (containing in mM: 212.7 sucrose, 5 KCl, 1.25 NaH 2 PO 4 , 10 MgCl 2 , 0.5 CaCl 2 , 26 NaHCO 3 , 10 dextrose). The slices were transferred to ACSF (containing in mM: 124 NaCl, 5 KCl, 1.25 NaH 2 PO 4 , 1 MgCl 2 , 2 CaCl 2 , 26 NaHCO 3 , 10 dextrose) for recovery at 30 C for 30 minutes then at room temperature for at least 30 minutes prior to recording. All solutions were continuously bubbled with carbogen (95% O2, 5% CO2), and the experiments were performed at 30 C-34 C.
Slice Processing and Microscopy with a Slide Scanner
For images in Figure 1B , mice were deeply anesthetized at P30 with isoflurane and perfused transcardially with 4% paraformaldehyde in phosphate buffered saline (PBS). Brains were post-fixed overnight, washed in PBS and 40 mm parasagittal sections were cut with a Leica VT1000S vibratome (Leica Instruments). They were then mounted on superfrost slides, dried and covered with ProLong antifade reagent containing DAPI (Molecular Probes) followed by a coverslip. Whole sections were imaged with an Olympus VS120 slide-scanning microscope.
Two-photon Imaging of Ca 2+ Signals and 2pFLIM
Two photon imaging was achieved by a custom-built microscope with a mode-locked Ti-sappire laser source (Carter and Sabatini, 2004; Chen et al., 2014) (Chameleon Vision II, 80 MHz, Coherent) . Photons were collected with fast photomultipler tubes (PMTs) (H7422-40MOD, Hamamatsu). A 60X (NA1.1) objective (Olympus) was used. Image acquisition was performed using a custom-written software ScanImage that ran in MATLAB (Chen et al., 2014; Pologruto et al., 2003) . For Ca 2+ imaging, 910nm was used as the excitation wavelength, and 128x128 pixel images were collected by frame scan at 4Hz.
CA1 neurons with basal GCaMP3 signals excluded from the nucleus were used for experiments since neurons with labeled nuclei were previously shown to have impaired calcium homeostasis and GCaMP3 function (Tian et al., 2009) . At the end of all Ca 2+ imaging experiments, 50mM KCl was applied to activate voltage-gated calcium channels as a positive control for cell health. FLIM was performed as described previously (Chen et al., 2014) . The FLIM board SPC-150 (Becker and Hickl GmbH) was used, and time-domain single photon counting was performed in 256 time channels. 920nm excitation wavelength was used to excite the donor fluorophore mEGFP in FLIM-AKAR. Figure 1F was constructed from the maximum projections along the z dimension of two regions of interests acquired with a twophoton microscope, at 3 frames per z slice and 1 mm per z step. All experiments were performed in the presence of 1 mM DPCPX to inhibit adenosine receptors, and 1 mM tetrodotoxin to block action potentials.
Ca
2+ Image Analysis
Each region of interest (ROI) corresponding to a single neuronal cell body was manually selected. The fluorescence signal for all pixels in a given ROI was averaged and plotted against time. The DF/F 0 was calculated as (F-F 0 )/F 0 , where F 0 is the fluorescence signal averaged over the entire baseline period (usually 2.5-3 minutes).
FLIM Image Analysis
Fluorescence lifetime curve fitting and the calculation of average lifetime over a particular region of interest were performed as described previously (Chen et al., 2014; Harvey et al., 2008; Yasuda et al., 2006) . Instrument response curve (IRF) was measured with double harmonic generation of urea crystals and used to deconvolve the fluorescence decay curve. The time constant for the free donor lifetime (t free ) was determined by transfecting the donor alone into HEK293T cells, and was determined to be 2.14ns. To determine the time constant for donors that have undergone FRET (t FRET ), FLIM-AKAR was transfected into HEK293T cells, and the best double exponential fit was performed with t free fixed at 2.14ns. t FRET was determined to be 0.69ns. These values of t free and t FRET were then used for double exponential fitting of lifetime distribution curves during all experiments.
Only images with photon count rates between 40,000 photons per second (40KHz) and 1.3MHz were used. The lower limit ensures accurate lifetime estimation based on our simulation, and gives a standard deviation of lifetime estimate of 0.0035ns. The upper limit ensures that we do not run into dead time and pile-up issues of the FLIM board.
For ROI analysis, somatic cytoplasm, nucleus and dendrite were segmented via a semi-automated software written in MATLAB that utilizes both intensity and lifetime data. The image segmentation was visually inspected and revised by the experimenter post automation.
The amplitudes of lifetime changes were quantitated as follows ( Figure S1A ): BaselineStart = lifetime measurements averaged over the first minute of baseline; BaselineEnd = lifetime measurements averaged over the last minute of baseline; BaselineMin = minimum lifetime measurement during baseline; TreatmentMin = minimum lifetime measurement after a particular drug flow À in; before the next drug flow in:
Dlifetime ðbaselineÞ = BaselineMin À BaselineStart; Dlifetime ðTreatmentÞ = TreatmentMin À BaselineEnd: Electrophysiology For Figure S3B , paired whole-cell voltage clamp recordings were taken from transfected hippocampal CA1 pyramidal neurons, identified by mRuby2 epifluorescence for PKIa-IRES-mRuby2 expressing cells, and neighboring untransfected control cells. Slices were perfused in ACSF containing 100 mM picrotoxin. Results from two conditions (10 mM NBQX or 10 mM (R)-CPP) were pooled for analysis. Whole-cell access to recorded neurons was made using 3-5 MU glass pipettes filled with internal solution containing (in mM): 135 CsMeSO4, 8 NaCl, 10 HEPES, 0.3 EGTA, 5 QX-314, 4 Mg-ATP, 0.3 Na-GTP, 0.1 spermine, at 293 mOsm and pH 7.24. Voltageclamp was performed using a Multiclamp 700B amplifier (Molecular Devices) with a 3 KHz Bessel filter, digitized at 10 KHz using a National Instruments data acquisition board, and recorded and analyzed using ScanImage. Input resistance and capacitance were calculated following whole-cell break-in by fitting a 5 mV test pulse with an exponential decay, and holding current measured when neurons were voltage-clamped to À70 mV.
For Figure S5 , visualized whole-cell current-clamp recordings were made from layer II/III regular-spiking pyramidal cells using MultiClamp 700A amplifier (Molecular Devices). Borosillicate glass recording pipettes (4-6 MU) were filled with intracellular solution containing (in mM): 130 K-Gluconate, 10 KCl, 0.2 EGTA, 10 HEPES, 4 Mg-ATP, 0.5 Na-GTP, 10 Na-Phosphocreatine, with or without 0.01 myristoylated PKI 14-22 amide, at 280-290mOsm and pH 7.25. Only cells with membrane potentials more negative than À65 mV, series resistance < 20 MU (8-18 MU, compensated at 80%), and input resistance larger than 100 MU were studied. Cells were excluded if input resistance changed > 15% over the entire experiment, with the exception of changes during bath application of the agonists. Data were filtered at 2 kHz and digitized at 5 kHz using Igor Pro (WaveMetrics Lake Oswego, Oregon). Synaptic responses were evoked every 15 s by stimulating layer IV with 0.2 ms pulses delivered through theta glass pipettes filled with ACSF. Intensity was adjusted to evoke a 4-6 mV response. Synaptic strength was quantified as the initial slope (the first 2 ms) of the EPSP. One cell per slice was used.
Pharmacology
Unless otherwise noted, all chemicals were applied via bath perfusion: they were either spiked into the perfusion reservoir, or premade buffers with the specified chemical concentrations were switched from one to another via a custom-made solution exchanger. Lifetime was allowed to stabilize before a new chemical was added; when there was no clear lifetime changes, 10 minutes were given before the addition of another chemical. Whenever possible, perturbation experiments were performed with interleaved brain slices, and the perfusion tubing was washed and changed for different drug conditions. The final concentrations of chemicals are specified in brackets: ACh (100 mM) was from Sigma; (+)-mus-iodide (10 mM), forskolin (50 mM), isoproterenol (1 mM), clozapine N-oxide (10 mM), scopolamine hydrobromide (10 mM), cyclopiazonic acid (30 mM, pre-incubation at room temperature for at least 35 minutes), phorbol 12, 13-dibutyrate (1 mM), GF 109203X (2 mM, and pre-incubation at room temperature for at least 35 minutes), (S)-3,5-DHPG (50 mM), DPCPX (1 mM), picrotoxin (100 mM), NBQX (10 mM) and (R)-CPP (10 mM), PKI 14-22 amide, myristoylated (10 mM, included in the internal solution in the patch pipette) were from Tocris Bioscience; tetrodotoxin citrate (1 mM) was from Abcam and Tocris; YM-254890 (1 mM, and pre-incubation at 32 C for at least 10 minutes) was from Wako; and 77-LH-28-1 (10 mM) was a gift from Eli Lilly and company.
For ACh puffing experiments, ACh (200 mM in ACSF) was puffed onto an apical or basal dendrite from a glass patch pipette via a picospritzer (Parker) at 2 psi, and approximately 30 mm from the dendrite.
QUANTIFICATION AND STATISTICAL ANALYSIS
Detailed information of sample descriptions and statistics can be found in Table S1 , and was also summarized in the Figure Legends Sample size n reported here refers to biological replicates of number of neurons. Figure S5C shows mean ± standard error of the mean (SEM). In all the other figures, each square represents a data point, black lines show median values with interquartile intervals.
Nonparametric two-tailed tests were used for all statistical analyses. For comparison between before and after drug application, and for comparison with paired electrophysiology recordings between PKI negative and positive neurons, Wilcoxon matched pairs signed rank test was used. For comparison between different treatment conditions, Mann Whitney test was used. For data in Figure S5 , the last 2.5 minutes of baseline or agonist application were averaged and used for statistical comparison. To ask if PKA activity is modulated by non-mAChR receptors that are Gaq coupled, Bonferroni correction was used to counteract the problem of multiple comparisons for more than one GPCR.
For experiments with mus, sample distributions in Figure 1J were used for power calculation to determine sample size. For the other experiments, standard replicate numbers in the field were used.
DATA AND SOFTWARE AVAILABILITY
The MATLAB programs for ScanImage for data acquisition and analysis are available at https://github.com/bernardosabatinilab/ SabalabSoftware_Nov2009. All other code is available upon request. The summary statistics of all the data are can be found in Table S1 .
